Cash · 2019–2025

Starling Oncology cash

$33.6M−32.4% · FY2025

Starling Oncology (STLN) reported $33.6M in cash for fiscal 2025, −32.4% year on year.

$2.4M2019$900,0002020$115M2021$14.0M2022$33.5M2023$49.7M2024$33.6M2025
Starling Oncology — Cash, 2019–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$33.6M−32.4%Open →
FY20242024-12-31$49.7M+48.3%Open →
FY20232023-12-31$33.5M+139.0%Open →
FY20222022-12-31$14.0M−87.8%Open →
FY20212021-12-31$115M+12,697.1%Open →
FY20202020-12-31$900,000−63.2%Open →
FY20192019-12-31$2.4M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +54.7%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Starling Oncology cash |url=https://companiesranked.com/en/company/starling-oncology/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Starling Oncology cash. CompaniesRanked. https://companiesranked.com/en/company/starling-oncology/cash-on-hand

BibTeX

@misc{companiesranked-en-company-starling-oncology-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Starling Oncology cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/starling-oncology/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001799191-26-000017 · August 6, 2026

{{cite web |title=Starling Oncology cash — 10-Q (0001799191-26-000017) |url=https://www.sec.gov/Archives/edgar/data/1799191/000179919126000017/toi-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Starling Oncology overview